{
  "id": "PK_BCRP_INHIB_SUBSTRATE",
  "name": "BCRP inhibition can increase exposure of BCRP substrates",
  "domain": "PK",
  "severity": "caution",
  "rule_class": "caution",
  "tags": ["exposure_increase"],
  "actions": [
    "Recognize that BCRP inhibition can increase exposure of some substrates (educational).",
    "Use extra caution for substrates where modest exposure changes may matter.",
    "Verify transporter relevance and interaction significance with primary sources."
  ],
  "logic": {
    "transporter": {
      "family": "ABCG2",
      "A_role": "substrate",
      "B_role": "inhibitor",
      "B_strength_in": ["moderate", "strong"]
    },
    "rationale": [
      "{B_name} can inhibit BCRP (ABCG2), an efflux transporter involved in limiting exposure of some drugs.",
      "Reduced efflux may increase {A_name} exposure in some contexts."
    ]
  },
  "explanation_template": "{B_name} may inhibit BCRP (ABCG2) and {A_name} is a BCRP substrate. This can increase {A_name} exposure and raise the risk of dose-related adverse effects (educational).",
  "references": [
    {
      "source": "Educational note",
      "citation": "Mechanistic pattern: efflux transporter inhibition + substrate can increase exposure."
    }
  ]
}
